Vesilute for Bladder Health & Urinary System Support — Bioregulators
Khavinson bioregulator peptide for bladder tissue regeneration and urinary function optimization.
Overview
Vesilute is a Khavinson bioregulator specifically targeting bladder and urinary system tissues for health optimization and functional support. Through DNA-level gene regulation in bladder epithelial cells, Vesilute promotes tissue repair, supports urinary function, and optimizes bladder aging. It's particularly valuable for overactive bladder, urinary incontinence, bladder aging, and urinary health maintenance.
Indications
- Overactive bladder and urinary urgency
- Urinary incontinence support
- Bladder tissue health and aging
- Urinary tract health optimization
- Post-urinary infection recovery
- Bladder function in aging
- Urinary system tissue repair
Mechanism of Action
Age-related bladder tissue decline, overactive bladder, or urinary incontinence
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Vesilute | 20 mg | Once daily | Bladder health maintenance and urinary support |
| Vesilute | 20 mg | Twice daily for first 2 months, then once daily | For overactive bladder or urinary dysfunction |
Safety & Contraindications
- Emerging evidence - Russian urology studies
- No reported adverse effects in clinical trials
- Not a replacement for overactive bladder medications
- Monitor urinary symptoms during use
- Consult urologist with severe bladder dysfunction
- Safe for long-term urinary health support